Revvity Gene Delivery (formerly SIRION Biotech)
- Home
- Companies
- Revvity Gene Delivery (formerly SIRION ...
- Services
- Antibody Drug Conjugate Services
Antibody Drug Conjugate Services
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each facet demands meticulous attention.
Most popular related searches
drug conjugate
in vitro cell
in vitro model
oncology therapeutic
oncology therapeutics
clinical stage
therapeutic antibody
therapeutic candidate
clinical development
therapeutic drug
At Revvity, we specialize in partnering with you to help expedite preclinical in-vitro cell engineering and screening processes for ADC therapeutic candidates through our comprehensive suite of services. This helps streamline development, accelerate progression towards clinical stages.
Our platform:
- From complex in-vitro model design to IND-enabling data generation.
- In-depth analysis covering high-throughput gene, phenotypic, and functional assessments.
- Flexible support ranging from rapid turnaround standard assays to fully customized projects for ADCs.